The Pharma Data
OCTOBER 15, 2020
. “This article is a valuable contribution because it simply observes the state of things, but to go a step further and say this is really bad because people aren’t doing what doctors want them to do is an opinion, not a fact,” said Bostwick, who was not part of the study.
Velocity Clinical Research
DECEMBER 6, 2023
In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. Gackowska has led international teams dedicated to clinical trials management, product launch, market access, marketing, and sales. and Europe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
FEBRUARY 21, 2022
Unger, who is a 1971 recipient of the Rensselaer Polytechnic Institute Mathematics and Science Medal, earned a Bachelor of Science (magna cum laude) in chemistry from Wright State University in Dayton, Ohio, and a Doctor of Medicine from the University of Cincinnati College of Medicine in Cincinnati, Ohio.
Velocity Clinical Research
JANUARY 3, 2024
Dr. Kirsten said, “Since the beginning of our career as internal medicine doctors and pneumologists, we realized that only clinical research holds the potential for innovation. About Marek Konieczny, MD, PhD Dr. Konieczny is a specialist in cardiology and internal medicine. and Europe.
The Pharma Data
MARCH 23, 2022
Dr. Barr oversaw the company’s Vaccines/Infectious Disease area during a period of high productivity, including the development of novel therapies for chronic hepatitis C and HIV-1 infections. Barr has held positions of increasing responsibility including leadership roles in oncology and infectious diseases clinical development.
The Pharma Data
JANUARY 21, 2021
“When a younger individual has a cardiovascular event, it will affect their quality of life going forward, their productivity, and their contribution to society,” Mora said in a hospital news release. 20 in the journal JAMA Cardiology. 20 in the journal JAMA Cardiology. ” Mora agreed. © 2021 HealthDay. .”
Delveinsight
AUGUST 3, 2021
The company expects full-year growth versus 2019 on the back of new product launches. According to analyst views, interventional cardiology sales grew at around 7% in the first quarter of 2021 versus 2020 with structural heart franchise WATCHMAN, ACURATE neo2, and SENTINEL. As per analysts, the company saw growth of 115.8%
Expert insights. Personalized for you.
52 
Let's personalize your content